Navigation Links
DataMotion Files Provisional Patent for Technology that Enables Easy and Secure Doctor-Patient Email Interaction
Date:7/2/2012

MORRISTOWN, N.J., July 2, 2012 /PRNewswire/ -- DataMotion (www.datamotion.com), innovator in cloud-based data delivery services, today announced it has filed a provisional patent for a new technology that will enable every U.S. citizen, along with millions of physicians and healthcare systems, to easily exchange sensitive healthcare data via email. The solution, which takes a new approach to digital certificates and S/MIME messaging, overcomes major obstacles to the adoption of secure email in healthcare. In particular, it pertains to The Direct Project, a national effort to drive efficiency in the exchange of healthcare information, spearheaded by the Office of the National Coordinator for Health IT, and promoted by the Obama administration under the Patient Protection and Affordable Care Act.

(Logo: http://photos.prnewswire.com/prnh/20120413/NE87365LOGO)

The Direct Project is based on digital certificates and S/MIME, which provides a secure, standards-based foundation for encrypted messaging. However, its adoption faces significant hurdles due to complexity for users and scalability. To exchange messages through this system, participants such as providers, medical systems and patients must first sign up and be configured to use new Direct email addresses. The magnitude of this challenge becomes evident when applied to the U.S. healthcare system, where more than 200 million adult citizens - and the majority of providers and medical systems - do not yet have Direct-enabled accounts, preventing them from securely exchanging messages.

To address these issues, DataMotion Co-founder and Chief Technology Officer, Bob Janacek, has filed a provisional patent titled "Method and Apparatus for Securely Communicating Using Public/Private Keys" that automates the creation and management of digital certificates, making it simple for doctors and patients to communicate over email in a secure, compliant way. Once this technology is in place, any time a physician attempts to send an email using The Direct Project, the message will be securely sent via the existing S/MIME method, regardless of whether or not the recipient is enrolled in the system. This allows physicians to get on with their work without introducing disruptions.

"The technology associated with our provisional patent makes it practical, for the first time, for patients and healthcare organizations to communicate securely using the Direct Project," Janacek said. "This is a critical capability that will improve healthcare in the United States. We simply must move beyond the U.S. Postal Service and the office visit as the primary forms of communications between doctors and patients if we are to truly have the best healthcare system in the world."

DataMotion is discussing the solution with U.S. health information service providers associated with The Direct Project, as well as electronic medical record vendors and healthcare integrators. Additionally, the technology could provide a much-needed solution in Europe, where medical records need to move freely and securely among E.U. member nations.

Like all DataMotion data-delivery services, this new capability will leverage the DataMotion Platform, a cloud-based Platform-as-a-Service (PaaS) that makes it simple for organizations to reduce the cost and complexity of exchanging sensitive information with employees, customers and partners in a secure and compliant way.

Millions of users worldwide rely on DataMotion solutions. The DataMotion Platform improves on traditional approaches by providing a unified, secure, cloud-based hub for delivering messages, files and electronic forms. It integrates disparate systems in a fully auditable manner and provides visibility into reporting of all transactions to ensure control. Its unique architecture offers flexibility to incorporate any number of systems, workflows and organizations. A true PaaS, it also is available as a transaction-based pay-as-you-go business option, enabling organizations to start with smaller deployments and scale as they grow.

About DataMotion
DataMotion enables organizations to dramatically reduce the cost and complexity of delivering electronic information to employees, customers and partners in a secure and compliant way. The company's core DataMotion Platform solves a broad range of business issues by providing a secure data delivery hub. The company's easy-to-use solutions for secure email, file transfer, forms processing and customer contact leverage the DataMotion Platform for unified data delivery. Millions of users worldwide rely on DataMotion to transparently improve business processes and reduce costs, while mitigating security and compliance risk. DataMotion is privately held and based in Morristown, N.J.

Media Contacts:

Monica Hutton
DataMotion
(973) 455-1245 x510
monicah@datamotion.com

Marty Querzoli
Davies Murphy Group (DMG)
(781) 418-2433
datamotion@daviesmurphy.com


'/>"/>
SOURCE DataMotion
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
2. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
3. Sunpeaks Ventures Files Defamation Lawsuit
4. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
5. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
6. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
7. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
8. World Renowned Inventor, Donald Spector, Develops Patent For Wireless Electric Acupuncture Patches
9. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
10. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
11. Celladon Corporation Receives Notice of Allowance from European Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... -- The innovator of COMBO ... s first dual therapy stent, introduces catheters for lower ... a global company specializing in the provision of life-changing ... to treat peripheral artery disease. The JADE™ and Scoreflex™ ... lower limb and arteriovenous (AV) fistula intervention. ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
Breaking Medicine Technology:
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the ... and suppliers for its inaugural Member Conference at the Paris Hotel in Las ... the operational health of America’s healthcare providers. , The conference was highlighted by ...
(Date:5/26/2016)... ... 2016 , ... The Woodlands at John Knox Village , Florida’s first ... for living and healing, celebrated its grand opening, today. The Woodlands at John Knox ... by Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... in Korea to support the company’s continued investment and strategic growth plans in ...
Breaking Medicine News(10 mins):